SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001561743-15-000030
Filing Date
2015-08-10
Accepted
2015-08-10 09:07:31
Documents
9
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kindred10qq-22015.htm 10-Q 544012
2 EXHIBIT 31.1 exhibit311q22015.htm EX-31.1 13246
3 EXHIBIT 32.1 exhibit321q22015.htm EX-32.1 6812
  Complete submission text file 0001561743-15-000030.txt   2817806

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT kin-20150630.xml EX-101.INS 594426
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kin-20150630.xsd EX-101.SCH 20036
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kin-20150630_cal.xml EX-101.CAL 42954
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kin-20150630_def.xml EX-101.DEF 86319
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kin-20150630_lab.xml EX-101.LAB 279503
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kin-20150630_pre.xml EX-101.PRE 159837
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36225 | Film No.: 151039368
SIC: 2834 Pharmaceutical Preparations